Justin Feng is a senior associate at Atlas Venture, investing in novel therapeutics. He previously held roles at MRL Venture Funds, Johnson and Johnson, and GRO Biosciences.
At firms with a similar stage, sector and check size.



One email when Justin's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJustin Feng is a senior associate at Atlas Venture, investing in novel therapeutics. He previously held roles at MRL Venture Funds, Johnson and Johnson, and GRO Biosciences.
Atlas Venture has not reported a check size. It invests at seed, series a.
A warm intro from a founder Atlas Venture backed works best.
principal scientist at GRO Biosciences; senior manager at Johnson and Johnson; senior associate at MRL Venture Funds; senior manager within the Transactions and Early Innovation Partnering teams at Johnson and Johnson.
Last updated 2026-10-15. Is this you? Ask for a correction.